-
Codeine increases risk of death in some children, FDA warns
SILVER SPRING, Md. — Children who take a class of opioid pain relievers after certain surgeries may be at risk of death, the Food and Drug Administration warned Wednesday.
The FDA issued the warning after receiving reports of three children who died and one who experienced a life-threatening case of respiratory depression after taking codeine following tonsil- and adenoid-removal surgery.
-
Teva launches generic chemotherapy drug
IRVINE, Calif. — A division of Teva Pharmaceutical Industries has launched a generic chemotherapy drug, the company said.
Teva Health Systems announced the introduction of oxaliplatin injection in the 50-mg and 100-mg strengths.
The drug is a generic version of Sanofi's Eloxatin, which had sales of $1.7 billion during the 12-month period ended in June, according to IMS Health.
Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.